Platelet BioGenesis

OverviewSuggest Edit

Platelet BioGenesis is a biotech company which makes human platelets from stem cells for clinical application. The Company has developed and patented a microfluidic bioreactor, and shown that functional platelets can be generated from human pluripotent stem cell cultures. By removing the volunteer donor, Platelet BioGenesis can make platelets that are cheaper, safer, and available on demand.

TypePrivate
Founded2014
HQCambridge, US
Websiteplateletbiogenesis.com

Recent NewsAll News

Latest Updates

Employees (est.) (Jan 2020)39(-4%)

Key People/Management at Platelet BioGenesis

Jonathan Thon

Jonathan Thon

CEO
Sven Karlsson

Sven Karlsson

President and Chief Business Officer
Show more

Platelet BioGenesis Office Locations

Platelet BioGenesis has an office in Cambridge
Cambridge, US (HQ)
325 Vassar St #2A
Show all (1)

Platelet BioGenesis Financials and Metrics

Summary Metrics

Founding Date

2014

Platelet BioGenesis total Funding

$41 m

Platelet BioGenesis latest funding size

$26.36 m

Time since last funding

4 months ago

Platelet BioGenesis investors

Platelet BioGenesis's latest funding round in September 2019 was reported to be $26.4 m. In total, Platelet BioGenesis has raised $41 m
Show all financial metrics

Platelet BioGenesis Online and Social Media Presence

Embed Graph

Platelet BioGenesis News and Updates

Platelet BioGenesis raises $26 mln

Platelet BioGenesis Inc said Sept 9 that it raised more than $26 million in a Series A round co-led by Ziff Capital Partners and Qiming Venture Partners USA. Existing investors Nest.Bio Ventures and eCoast Angels also participated in the round, among others. Platelet BioGenesis has developed a platf…

Platelet BioGenesis Blogs

Platelet BioGenesis Receives $2.3 Million Award from the Medical Technology Enterprise Consortium

The post Platelet BioGenesis Receives $2.3 Million Award from the Medical Technology Enterprise Consortium appeared first on Platelet BioGenesis.

Platelet BioGenesis Receives Contract Worth Up to $56 Million from BARDA

The post Platelet BioGenesis Receives Contract Worth Up to $56 Million from BARDA appeared first on Platelet BioGenesis.

Fortune Term Sheet: Health & Life Science Deals

The post Fortune Term Sheet: Health & Life Science Deals appeared first on Platelet BioGenesis.

Platelet BioGenesis brings in $26M

The post Platelet BioGenesis brings in $26M appeared first on Platelet BioGenesis.

Axios – Venture Capital Deals

The post Axios – Venture Capital Deals appeared first on Platelet BioGenesis.

Endpoints News: Platelet BioGenesis Raises $26M Plus

The post Endpoints News: Platelet BioGenesis Raises $26M Plus appeared first on Platelet BioGenesis.
Show more

Platelet BioGenesis Frequently Asked Questions

  • When was Platelet BioGenesis founded?

    Platelet BioGenesis was founded in 2014.

  • Who are Platelet BioGenesis key executives?

    Platelet BioGenesis's key executives are Jonathan Thon and Sven Karlsson.

  • How many employees does Platelet BioGenesis have?

    Platelet BioGenesis has 39 employees.

  • Who are Platelet BioGenesis competitors?

    Competitors of Platelet BioGenesis include Innate Pharma, ProtoKinetix and DBV Technologies.

  • Where is Platelet BioGenesis headquarters?

    Platelet BioGenesis headquarters is located at 325 Vassar St #2A, Cambridge.

  • Where are Platelet BioGenesis offices?

    Platelet BioGenesis has an office in Cambridge.

  • How many offices does Platelet BioGenesis have?

    Platelet BioGenesis has 1 office.